Former Novartis Executive Sentenced to Probation for Role in Generic Drug Price-Fixing Scheme
Hector Kellum, a former senior executive of Novartis unit Sandoz, has been sentenced to one year of probation by a U.S. court. Kellum had previously pleaded guilty to participating in a scheme aimed at fixing prices for generic medicines.
The case, which dates back to 2020, unfolded in Philadelphia federal court, where Kellum admitted to his involvement in manipulating the prices of clobetasol and nystatin triamcinolone cream. Clobetasol is commonly prescribed to treat eczema and psoriasis, while nystatin triamcinolone cream is used as an anti-fungal medication.
According to reports by Reuters, Kellum’s guilty plea also involved an agreement to cooperate with the government’s broader investigation into antitrust violations within the generic drug industry. Prosecutors revealed that one of Kellum’s alleged collaborators in the scheme was Ara Aprahamian, a former sales and marketing executive at Taro Pharmaceutical Industries, who faced charges related to price-fixing and bid-rigging.
Despite the allegations against Aprahamian, prosecutors requested the dismissal of the case last year. Aprahamian had pleaded not guilty to charges, including price-fixing and bid-rigging, in Philadelphia federal court.
Source: Reuters
Featured News
Judge Allows FTC Antitrust Case Against Amazon to Move Forward
Oct 1, 2024 by
CPI
SAP Leader Urges Caution on EU AI Rules, Warns of Competitive Disadvantage
Oct 1, 2024 by
CPI
Colorado’s Grocery Workers Unite to Oppose $24.6 Billion Supermarket Merge
Oct 1, 2024 by
CPI
Canada’s Competition Bureau Warns Businesses of Tougher Enforcement
Oct 1, 2024 by
CPI
Top Antitrust Lawyers Launch New Boutique Firm
Oct 1, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Refusal to Deal
Sep 27, 2024 by
CPI
Antitrust’s Refusal-to-Deal Doctrine: The Emperor Has No Clothes
Sep 27, 2024 by
Erik Hovenkamp
Why All Antitrust Claims are Refusal to Deal Claims and What that Means for Policy
Sep 27, 2024 by
Ramsi Woodcock
The Aspen Misadventure
Sep 27, 2024 by
Roger Blair & Holly P. Stidham
Refusal to Deal in Antitrust Law: Evolving Jurisprudence and Business Justifications in the Align Technology Case
Sep 27, 2024 by
Timothy Hsieh